Healthcare & Life Sciences
Egle Therapeutics
Germanyegle-therapeutics.com/
Egle Therapeutics is a series a startup based in France. 1 investor tracked. Status: acquired.
Acquiredseries-a
series-a
Stage
2018
Founded
1
Investors
About Egle Therapeutics
Based in Germany, Egle Therapeutics is a startup founded in 2018. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Egle Therapeutics is a biotechnology company developing novel immunotherapies. They focus on T-cell immunotherapies to treat autoimmune and inflammatory diseases, as well as cancer.
Explore Egle Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.